136 related articles for article (PubMed ID: 3313099)
61. Long-term follow-up of trigeminal neuralgia treatment using a linear accelerator.
Kubicek GJ; Hall WA; Orner JB; Gerbi BJ; Dusenbery KE
Stereotact Funct Neurosurg; 2004; 82(5-6):244-9. PubMed ID: 15637446
[TBL] [Abstract][Full Text] [Related]
62. Phenytoin in topical formulations augments pain reduction of other topically applied analgesics in the treatment of trigeminal neuralgia.
Kopsky DJ; Keppel Hesselink JM
J Clin Anesth; 2017 May; 38():154-155. PubMed ID: 28372657
[No Abstract] [Full Text] [Related]
63. Trigeminal neuralgia: current concepts and management.
Das B; Saha SP
J Indian Med Assoc; 2001 Dec; 99(12):704-9. PubMed ID: 12022221
[TBL] [Abstract][Full Text] [Related]
64. [Treatment of typical trigeminus neuralgias. Overview of the current state of drug and surgical therapy].
Möbius E; Leopold HC; Paulus WM
Fortschr Med; 1984 Oct; 102(38):935-9. PubMed ID: 6149988
[TBL] [Abstract][Full Text] [Related]
65. Challenges recruiting to a proof-of-concept pharmaceutical trial for a rare disease: the trigeminal neuralgia experience.
Zakrzewska JM; Palmer J; Bendtsen L; Di Stefano G; Ettlin DA; Maarbjerg S; Obermann M; Morisset V; Steiner D; Tate S; Cruccu G
Trials; 2018 Dec; 19(1):704. PubMed ID: 30587219
[TBL] [Abstract][Full Text] [Related]
66. Baclofen as an analgesic in chronic peripheral nerve disease.
Terrence CF; Fromm GH; Tenicela R
Eur Neurol; 1985; 24(6):380-5. PubMed ID: 4065157
[TBL] [Abstract][Full Text] [Related]
67. Baclofen in Parkinson's disease.
Lees AJ; Shaw KM; Stern GM
J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):707-8. PubMed ID: 355602
[TBL] [Abstract][Full Text] [Related]
68. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
Beraha EM; Salemink E; Goudriaan AE; Bakker A; de Jong D; Smits N; Zwart JW; Geest DV; Bodewits P; Schiphof T; Defourny H; van Tricht M; van den Brink W; Wiers RW
Eur Neuropsychopharmacol; 2016 Dec; 26(12):1950-1959. PubMed ID: 27842939
[TBL] [Abstract][Full Text] [Related]
69. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
70. A double-blind trial with the antispasticity drug Lioresal in 15 paraplegics with upper neuron lesions.
Haubensak K
Urol Int; 1977; 32(2-3):198-201. PubMed ID: 333693
[TBL] [Abstract][Full Text] [Related]
71. An open study of botulinum-A toxin treatment of trigeminal neuralgia.
Brenner SR
Neurology; 2006 May; 66(9):1458-9; author reply 1458-9. PubMed ID: 16682696
[No Abstract] [Full Text] [Related]
72. Baclofen in the elderly stroke patient its side-effects and pharmacokinetics.
Hulme A; MacLennan WJ; Ritchie RT; John VA; Shotton PA
Eur J Clin Pharmacol; 1985; 29(4):467-9. PubMed ID: 3912190
[TBL] [Abstract][Full Text] [Related]
73. Drug treatment of trigeminal neuralgia with sympatho- and parasympatholytics.
Kränzl B; Kränzl C
J Maxillofac Surg; 1976 Mar; 4(1):56-60. PubMed ID: 1062477
[TBL] [Abstract][Full Text] [Related]
74. Glossopharyngeal neuralgia: successful treatment with baclofen.
Ringel RA; Roy EP
Ann Neurol; 1987 May; 21(5):514-5. PubMed ID: 3592645
[No Abstract] [Full Text] [Related]
75. Prostatodynia--physiological characteristics and rational management with muscle relaxants.
Osborn DE; George NJ; Rao PN; Barnard RJ; Reading C; Marklow C; Blacklock NJ
Br J Urol; 1981 Dec; 53(6):621-3. PubMed ID: 7032641
[TBL] [Abstract][Full Text] [Related]
76. Treatment of self-injurious behaviour with a GABA (gamma-aminobutyric acid) analogue.
Primrose DA
J Ment Defic Res; 1979 Sep; 23(3):163-73. PubMed ID: 390158
[TBL] [Abstract][Full Text] [Related]
77. Clinical effects of multiple sclerosis therapy.
Jaffe R
Neurology; 1979 May; 29(5):760. PubMed ID: 375123
[No Abstract] [Full Text] [Related]
78. Baclofen-induced catatonia.
Pauker SL; Brown R
J Clin Psychopharmacol; 1986 Dec; 6(6):387-8. PubMed ID: 3805341
[No Abstract] [Full Text] [Related]
79. Baclofen-induced toxicity in renal disease with neurotoxicity and skin rash.
Pathak LK; Athavale A; Martinez I
Proc (Bayl Univ Med Cent); 2019 Jul; 32(3):425-426. PubMed ID: 31384209
[TBL] [Abstract][Full Text] [Related]
80. Effect of baclofen on seizure frequency.
Seyfert S
Arch Neurol; 1984 Feb; 41(2):134. PubMed ID: 6691803
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
